Zai Lab Ltd (ZLAB) Stock Analysis

Zai Lab Ltd (ZLAB) is a publicly traded company in the HEALTHCARE sector. It trades at $17.15, carries a market capitalization of $1.92B. This page summarizes the public market data, fundamentals, and frequently asked questions for ZLAB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.15
• Market Cap: $1.92B
• EPS: $-1.70
• 52-Week High: $44.34
• 52-Week Low: $15.96

Market Sentiment

Zai Lab Ltd currently has a Neutral sentiment score of 0.11.

About Zai Lab Ltd

Zai Lab Limited (ZLAB) is a prominent biopharmaceutical company headquartered in Shanghai, China, dedicated to the discovery, development, and commercialization of innovative therapies targeting cancer, autoimmune disorders, and infectious diseases. With a robust pipeline of novel drug candidates and a strategic focus on fostering global partnerships, Zai Lab is well-equipped to meet the significant unmet medical needs in China and internationally. The company is positioned to leverage the ra...

GNG Research Analysis

GNG Research scores Zai Lab Ltd (ZLAB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ZLAB.

Frequently Asked Questions

Does ZLAB pay dividends?

Zai Lab Ltd (ZLAB) does not currently pay a regular dividend.

What is ZLAB's market cap?

Zai Lab Ltd (ZLAB) has a market capitalization of $1.92B with a current stock price of $17.15.